Dual-energy computed tomography (DECT) is an advanced imaging technique that acquires data using two distinct X-ray energy spectra, typically at 80 and 140 kVp, to differentiate materials based on their atomic number and electron density. This capability allows for the enhanced visualisation of various pathologies, including bone marrow oedema (BMO), by providing high-resolution images with notable energy spectral separation while maintaining radiation doses comparable to conventional CT. DECT's ability to create colour-coded virtual non-calcium (VNCa) images has proven particularly valuable in detecting traumatic bone marrow lesions (BMLs) and subtle fractures, offering a reliable alternative or complement to MRI. DECT has emerged as a significant tool in the detection and characterisation of bone marrow pathologies, especially in traumatic injuries. Its ability to generate high-resolution images and distinguish between different tissue types makes it a valuable asset in clinical diagnostics. With its comparable diagnostic accuracy to MRI and the added advantage of reduced examination time and increased availability, DECT represents a promising advancement in the imaging of BMO and related conditions.